Pneumonia, Pneumococcal Clinical Trial
Official title:
Comparison Between Ceftriaxone and Levofloxacin on Cytokine Expression Over Time in Severe Pneumococcal Pneumonia
The purpose of this study is to compare levofloxacin vs ceftriaxone impact on the cytokine production in patients with pneumococcal pneumonia.
Bacterial alveolar invasion is followed by a compartmentalized inflammatory response. Data
suggest that some antimicrobials may induce a differential release of cytokines, with the
potential of either accelerating or down regulating cytokine production.
The aim of our study was to compare the effects of ceftriaxone compared with levofloxacin on
cytokine systemic concentrations in patients with pneumococcal pneumonia.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Completed |
NCT05526716 -
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)
|
Phase 3 | |
| Completed |
NCT02116998 -
Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae
|
Phase 2 | |
| Completed |
NCT00744263 -
Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
|
Phase 4 | |
| Completed |
NCT04559204 -
Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4
|
Phase 4 | |
| Active, not recruiting |
NCT04923035 -
Paediatric Pneumococcal Pneumonia in Malaysia Prior to and During Pneumococcal Conjugate Vaccine (PCV) Implementation
|
||
| Completed |
NCT02961231 -
Evaluation of PCV Schedules in a Naive Population in Vietnam
|
Phase 4 | |
| Completed |
NCT03460730 -
Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)
|
Phase 1 | |
| Active, not recruiting |
NCT05079152 -
Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4
|
Phase 4 | |
| Completed |
NCT04790851 -
Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4
|
Phase 4 | |
| Terminated |
NCT03058211 -
Myocardial Injury and Severe Pneumococcal Pneumonia
|
||
| Recruiting |
NCT04108845 -
Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months
|
Phase 1 | |
| Completed |
NCT03197376 -
Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants
|
Phase 3 | |
| Active, not recruiting |
NCT05412030 -
A Phase 2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of AFX3772 Vaccine in Healthy Infants
|
Phase 2 | |
| Completed |
NCT03950856 -
Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020)
|
Phase 3 | |
| Completed |
NCT04464291 -
An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years
|
N/A | |
| Not yet recruiting |
NCT04357522 -
Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers
|
Phase 3 | |
| Completed |
NCT03896477 -
Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants
|
Phase 3 | |
| Completed |
NCT05420961 -
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)
|
Phase 3 | |
| Completed |
NCT04278248 -
Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above
|
Phase 3 |